Literature DB >> 9028719

Are risk factors for conversion to NIDDM similar in high and low risk populations?

S M Haffner1, H Miettinen, M P Stern.   

Abstract

Mexican Americans have an increased risk of non-insulin-dependent diabetes mellitus (NIDDM) relative to non-Hispanic whites which is only partially explained by their excess overall obesity and unfavourable body fat distribution. Non-diabetic Mexican Americans have hyperinsulinaemia and insulin resistance relative to non-Hispanic whites. We therefore hypothesized that the insulin resistance might be a more important predictor of NIDDM in high-risk populations characterized by obesity and insulin resistance, while compromised insulin secretion might be a more important risk factor for NIDDM in low-risk populations. We assessed the ability of ethnicity (Mexican American vs non-Hispanic white), age, overall adiposity (body mass index [BMI]), unfavourable body fat distribution (as assessed by waist-to-hip ratio [WHR]), glucose tolerance (impaired glucose tolerance vs normal glucose tolerance), fasting insulin and compromised insulin secretion (as assessed by increment in insulin to the increment in glucose over the first 30 min of an oral glucose tolerance test (delta I30/delta G30)) to predict future NIDDM. In the 8-year follow-up of the San Antonio Heart Study, NIDDM developed in 11.7% (107/914) of Mexican Americans and in 5.0% (18/362) of non-Hispanic whites (p < 0.001). Multivariate predictors of NIDDM by multiple logistic regression analysis included increased age, BMI, WHR, fasting insulin and impaired glucose tolerance and decreased insulin secretion. The strongest independent predictors of NIDDM were high fasting insulin and decreased insulin secretion. These risk factors predicted NIDDM equally well in high and low-risk populations.

Entities:  

Mesh:

Year:  1997        PMID: 9028719     DOI: 10.1007/s001250050643

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

Review 1.  There really is an epidemic of type 2 diabetes.

Authors:  S Colagiuri; K Borch-Johnsen; C Glümer; D Vistisen
Journal:  Diabetologia       Date:  2005-07-09       Impact factor: 10.122

Review 2.  A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies.

Authors:  Adrian Bagust; Marc Evans; Sophie Beale; Philip D Home; Andrew S Perry; Murray Stewart
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study.

Authors:  C Lorenzo; K Williams; S M Haffner
Journal:  Diabet Med       Date:  2012-08       Impact factor: 4.359

4.  Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study.

Authors:  M Wallander; M Bartnik; S Efendic; A Hamsten; K Malmberg; J Ohrvik; L Rydén; A Silveira; A Norhammar
Journal:  Diabetologia       Date:  2005-09-06       Impact factor: 10.122

5.  The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study.

Authors:  Tuccinardi Dario; Giorgino Riccardo; Pieralice Silvia; Watanabe Mikiko; Maggi Daria; Palermo Andrea; Defeudis Giuseppe; Fioriti Elvira; Pozzilli Paolo; Manfrini Silvia
Journal:  Acta Diabetol       Date:  2020-11-13       Impact factor: 4.280

6.  Genetic linkage of oxidative stress with cardiometabolic traits in an intercross derived from hyperlipidemic mouse strains.

Authors:  Daniela T Fuller; Andrew T Grainger; Ani Manichaikul; Weibin Shi
Journal:  Atherosclerosis       Date:  2019-12-03       Impact factor: 5.162

7.  Impaired glucose tolerance and obesity as effect modifiers of ethnic disparities of the progression to diabetes: the San Antonio Heart Study.

Authors:  Carlos Lorenzo; Roger Lee; Steven M Haffner
Journal:  Diabetes Care       Date:  2012-08-24       Impact factor: 19.112

8.  Modeling the impact of prevention policies on future diabetes prevalence in the United States: 2010-2030.

Authors:  Edward W Gregg; James P Boyle; Theodore J Thompson; Lawrence E Barker; Ann L Albright; David F Williamson
Journal:  Popul Health Metr       Date:  2013-09-18

9.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.